Royal Bank Of Canada reaffirmed their buy rating on shares of Wright Medical Group N.V. (NASDAQ:WMGI) in a research note issued to investors on Tuesday. Royal Bank Of Canada currently has a $31.00 price target on the medical device company’s stock.

Several other equities research analysts have also recently weighed in on the company. Oppenheimer Holdings, Inc. set a $30.00 target price on Wright Medical Group N.V. and gave the stock a hold rating in a report on Thursday, August 3rd. Cantor Fitzgerald initiated coverage on Wright Medical Group N.V. in a research note on Thursday, June 29th. They set an overweight rating and a $33.00 price target on the stock. BidaskClub downgraded Wright Medical Group N.V. from a hold rating to a sell rating in a report on Saturday, June 10th. Jefferies Group LLC restated a buy rating and issued a $33.00 price objective on shares of Wright Medical Group N.V. in a report on Friday, August 4th. Finally, Piper Jaffray Companies reaffirmed a buy rating and issued a $34.00 price objective on shares of Wright Medical Group N.V. in a research note on Thursday, August 3rd. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Wright Medical Group N.V. has an average rating of Buy and a consensus target price of $32.11.

Wright Medical Group N.V. (NASDAQ:WMGI) traded up 1.62% during mid-day trading on Tuesday, reaching $26.40. 100,747 shares of the company’s stock traded hands. The stock’s 50 day moving average is $27.65 and its 200-day moving average is $28.07. Wright Medical Group N.V. has a 52 week low of $20.50 and a 52 week high of $31.53. The stock’s market capitalization is $2.76 billion.

Wright Medical Group N.V. (NASDAQ:WMGI) last announced its quarterly earnings data on Wednesday, August 2nd. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.02. Wright Medical Group N.V. had a negative return on equity of 6.22% and a negative net margin of 36.04%. The company had revenue of $179.69 million for the quarter, compared to analysts’ expectations of $178.17 million. During the same quarter in the prior year, the firm earned ($0.11) earnings per share. Wright Medical Group N.V.’s revenue was up 5.3% compared to the same quarter last year. On average, equities analysts anticipate that Wright Medical Group N.V. will post ($0.29) EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/04/wright-medical-group-n-v-s-wmgi-buy-rating-reaffirmed-at-royal-bank-of-canada.html.

In related news, SVP Jennifer S. Walker sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $28.00, for a total transaction of $560,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 3.50% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Palo Alto Investors LLC grew its holdings in Wright Medical Group N.V. by 0.9% in the first quarter. Palo Alto Investors LLC now owns 2,628,193 shares of the medical device company’s stock worth $81,789,000 after purchasing an additional 23,600 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of Wright Medical Group N.V. by 30.6% during the second quarter. Victory Capital Management Inc. now owns 1,039,308 shares of the medical device company’s stock worth $28,571,000 after purchasing an additional 243,630 shares in the last quarter. Blue Jay Capital Management LLC increased its position in shares of Wright Medical Group N.V. by 4.7% during the second quarter. Blue Jay Capital Management LLC now owns 320,420 shares of the medical device company’s stock worth $8,808,000 after purchasing an additional 14,255 shares in the last quarter. Westfield Capital Management Co. LP increased its position in shares of Wright Medical Group N.V. by 13.8% during the second quarter. Westfield Capital Management Co. LP now owns 2,425,566 shares of the medical device company’s stock worth $66,679,000 after purchasing an additional 293,687 shares in the last quarter. Finally, Spark Investment Management LLC acquired a new position in shares of Wright Medical Group N.V. during the first quarter worth $1,300,000.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Stock Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related stocks with our FREE daily email newsletter.